DEL BASSO, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 667
AS - Asia 345
EU - Europa 320
AF - Africa 1
Totale 1.333
Nazione #
US - Stati Uniti d'America 658
CN - Cina 233
IE - Irlanda 152
SE - Svezia 126
TR - Turchia 82
SG - Singapore 23
FI - Finlandia 10
CA - Canada 9
IT - Italia 7
AT - Austria 6
DE - Germania 5
BE - Belgio 3
GB - Regno Unito 3
IN - India 3
UA - Ucraina 3
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
MN - Mongolia 1
NO - Norvegia 1
PH - Filippine 1
RO - Romania 1
VN - Vietnam 1
Totale 1.333
Città #
Chandler 245
Dublin 152
Izmir 66
Dearborn 62
New York 51
Nanjing 50
Beijing 42
Princeton 34
Ashburn 32
Wilmington 20
Hebei 19
Nanchang 18
Shanghai 18
Kocaeli 15
Hefei 11
Shenyang 11
Fremont 10
Helsinki 10
Kunming 9
Singapore 9
Tianjin 9
Toronto 8
Jiaxing 7
Seattle 7
Changsha 6
Hangzhou 6
Vienna 6
Jinan 5
Norwalk 5
Brussels 3
Guangzhou 3
Ningbo 3
Pune 3
Shaoxing 3
Fuzhou 2
Jacksonville 2
Parma 2
Turin 2
Zhengzhou 2
Ann Arbor 1
Baotou 1
Budapest 1
Cambridge 1
Changchun 1
Chongqing 1
Denver 1
Edinburgh 1
Geislingen an der Steige 1
Grafing 1
Hanoi 1
Istanbul 1
Lishui 1
Manila 1
Miami 1
Oslo 1
Prague 1
Richmond 1
Rockville 1
San Francisco 1
San Mateo 1
Taizhou 1
Timisoara 1
Ulan Bator 1
Washington 1
Zanjan 1
Totale 994
Nome #
Are tryptase and cathepsin D related to Helicobacter pylori infection and mucosal gastrin in peptic ulcer? 58
[Cisapride and sucralfate in dyspepsia associated with duodenogastric reflux gastritis] 57
Gastrin-17 (G-17) as a sensitive serological bio-marker for diagnosis of gastro-esophageal reflux disease (GERD) independently of H. pylori status 53
Serum pepsinogen C: a useful marker of Helicobacter pylori eradication? 52
[Ca 19-9 in the diagnosis of pancreatic carcinoma] 51
Cytology in the diagnosis of pancreatic cancer 50
Duodenogastric reflux gastritis: Does aetiology influence the picture? 48
[Alcohol-dependent mast cell activation in ulcer] 47
Gastric juice polymerase chain reaction (PCR) for Helicobacter pylori (Hp) diagnosis: An alternative to histology? 47
Different effects of H. pylori water extracts on cytokines, pepsinogen C and gastrin mucosal release in patients with or without duodenal ulcer 45
Does alcohol activate mast cells in peptic ulcer? 44
Comparison of two newly identified tumor markers (CAR-3 and DU-PAN-2) with CA 19-9 in patients with pancreatic cancer 43
Early drop in anti Helicobacter pylori IgG titre after eradication therapy with clarithromycin 43
Gastric juice polymerase chain reaction: an alternative to histology in the diagnosis of Helicobacter pylori infection 42
Biochemical and histopathological aspects in duodenogastric reflux gastritis patients with or without prior cholecystectomy 42
A new method for detecting anti Helicobacter pylori antibodies: An analytical and clinical evaluation 40
Analysis of Helicobacter pylori vacA and cagA genotypes and serum antibody profile in benign and malignant gastroduodenal diseases 40
[Changes in the pattern of serum biliary acids and lipoprotein picture during therapy with biliary acids in cholesterol lithiasis] 39
Do CA 19-9 and TPA play a minor role as compared to AFP in diagnosing primary hepatocellular carcinoma? 39
Helicobacter pylori cytotoxic genotype is associated with peptic ulcer and influences serology 39
Helicobacter pylori serology in patients with chronic gastritis 39
Computed tomography in the identification of gallstones likely to respond to UDCA 38
Limits of CEA and ferritin in the diagnosis of pancreatic cancer 38
Serum pepsinogens A and C in monitoring Helicobacter pylori (Hp) status after the cure: A prospective 4 year study 38
TRATTAMENTO MEDICO DELLA LITIASI COLESTEROLICA: STUDIO PROSPETTICO RANDOMIZZATO CON ACIDI BILIARI 36
Renal tubular dysfunction in pancreatic cancer and chronic pancreatitis 35
Pancreolauryl test in chronic pancreatitis 33
Helicobacter pylori infection and serum IgG avidity [2] 32
Helicobacter pylori infection enhances mucosal interleukin-1β, interleukin-6, and the soluble receptor of interleukin-2 32
[The role of the laboratory in the diagnosis and monitoring of Helicobacter pylori infection] 29
LA CLEBOPRIDE NELLE MANIFESTAZIONI CLINICHE DA GASTRITE DA REFLUSSO. STUDIO PROSPETTICO RANDOMIZZATO, CROSS-OVER, IN DOPPIA CIECO 28
Serum elastase 1 and immunoreactive trypsin in chronic pancreatic disease: Is there any relationship with trypsin inhibitors? 27
Influence of Helicobacter pylori on tryptase and cathepsin D in peptic ulcer 24
Sucralfate and cisapride in the treatment of duodenogastric reflux and dyspepsia: A randomized study 23
Totale 1.371
Categoria #
all - tutte 5.599
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.599


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201989 0 0 0 0 0 0 0 0 0 0 81 8
2019/2020235 83 23 0 0 17 52 29 4 5 19 3 0
2020/202128 0 1 2 0 0 0 1 0 4 18 1 1
2021/2022115 1 0 0 10 2 2 1 21 7 1 11 59
2022/2023644 51 74 31 90 34 80 3 50 195 5 28 3
2023/2024182 8 24 10 2 14 78 3 10 7 6 20 0
Totale 1.371